Explore our latest Lundbeck Magazine

Our new magazine is out.

VIDEO: The life of a Lundbeck graduate

Meet two of our current graduates and hear why they chose to work for Lundbeck.

Watch the film here

VIDEO: Meet Xue Bing

Ambitious goals and hard work – that’s what 46-year-old Xue Bing’s life revolved around. As cofounder of a rapidly growing teambuilding firm, he was realizing the high achiever’s dream. His job was to motivate and excite other people – but he lost his own spark to severe depression.

Watch his story

Annual Report 2018

Our Annual Report for 2018 is out.

Read and download the report

Latest releases

Feb 18, 2019 ı Corporate Releases

Lundbeck increases its share capital by 5,631 shares (0.0028 % of outstanding shares) as a result of exercise of employee warrants

Feb 14, 2019 ı Corporate Releases

Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder

View all releases

Join Lundbeck

Q4 2018 financial results

Watch the investor presentation

Download the Q4 2018 release

Latest feature

February 2019:

Lundbeck takes part in a comprehensive initiative to understand the blood-brain barrier

Read more

Investor portal

DK

Modtag din invitation til årets generalforsamling elektronisk. Tilmeld din mail via investorportalen.

UK

Receive your invitation to this year’s AGM electronically. Sign-up your email via the Investor Portal.

Corporate film

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain diseases.

Page last modified 18 February 2019

H. Lundbeck A/S Ottiliavej 9 | 2500 | Valby | Denmark | Phone +45 3630 1311 | Fax +45 3630 1940

You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.